CJC-1295 in Grandcour — GHRH Analog Research Guide
CJC-1295 research guide for Grandcour. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
For anyone in Grandcour trying to locate CJC-1295, the foundational reality is that this compound is available only through an online research supply market. This global online supply model is ultimately a quality advantage — top vendors distinguish themselves through rigorous testing in ways no local retailer can match. The key verification criteria for CJC-1295 are HPLC purity ≥98%, molecular identity established via mass spectrometry, and a bacterial endotoxin panel — all documented in a batch-matched Certificate of Analysis. This guide guides Grandcour researchers through that evaluation process and explains how to verify CJC-1295 vendor quality step by step.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Grandcour comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source CJC-1295 — Vendor Guide
Before assessing any particular supplier, build a clear picture of what a proper COA looks like — so you can tell whether a COA is complete and credible. The HPLC chromatogram is the most important document in the COA: it should show a dominant main peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be 98% or higher. For Grandcour researchers evaluating vendors with limited track records: a modest first purchase to test the product before scaling up your order is what experienced peptide researchers consistently do. Hold lyophilised CJC-1295 at −20°C until ready to use; reconstitute only the quantity required for your immediate research and return unused portion to the freezer.
Order CJC-1295 — ships to Grandcour
COA-verified · International tracking · Research grade
CJC-1295 is supplied strictly for research applications and is not approved for human use by the FDA or equivalent regulatory bodies — all information here is for educational purposes only. Proper handling of CJC-1295 requires careful sterile procedure — swabbed septum with alcohol prep pad, new needle for each draw, clean preparation area — and temperature control throughout the entire workflow. Endotoxin testing in the CJC-1295 COA is absolutely required — gram-negative bacterial endotoxins can trigger dangerous immune responses at minute levels, and no pricing advantage justifies skipping this verification. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not approved for human use and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
